Details

MIPS - Quality Measures - Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)

Quality Measures
Category QUALITY
Description Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have diabetes OR a current or prior Left Ventricular Ejection Fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy
eMeasure ID
First Performance Year 2017
Last Performance Year
Metric Type Single Performance Rate
National Quality Strategy Domain ECC
Measure Type Process
eMeasure UUID
NQF eMeasure ID
NQF ID 0066
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward American Heart Association
Submission Methods Registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_118_Registry.pdf
Web Interface Measure Spec
Claims Measure Spec

Back to List